Pharming Group's total assets for Q4 2025 were €425.52M, an increase of 5.44% from the previous quarter. PHAR total liabilities were €189.68M for the fiscal quarter, a 6.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.